These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 296180)
21. An automatic substitution policy for cefazolin. Nakagawa RS Can J Hosp Pharm; 1986 Aug; 39(4):105-6. PubMed ID: 10278469 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of drug-procurement alternatives. May BE; Herrick JD Am J Hosp Pharm; 1984 Jul; 41(7):1373-8. PubMed ID: 6465153 [TBL] [Abstract][Full Text] [Related]
23. Drug Price Index declines as prices weaken for older drugs. Hosp Mater Manage; 1986 May; 11(5):21-2. PubMed ID: 10277138 [No Abstract] [Full Text] [Related]
24. HMM drug price index advances at 4% annual rate. Hosp Mater Manage; 1987 Nov; 12(11):14-5. PubMed ID: 10285402 [No Abstract] [Full Text] [Related]
25. Survey shows hospitals expand generic drug use. Jaffe MO Health Care Week; 1979 Feb; 2(30):1, 3. PubMed ID: 10240113 [No Abstract] [Full Text] [Related]
26. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products. Becker C Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428 [TBL] [Abstract][Full Text] [Related]
27. Competition of high-priced new drugs holds down prices of older drugs. Hosp Purch Manage; 1982 May; 7(5):14-5. PubMed ID: 10255154 [No Abstract] [Full Text] [Related]
28. Evaluating group purchasing through a prime vendor. Johnson LH; Herrick JD Am J Hosp Pharm; 1984 Sep; 41(9):1783-8. PubMed ID: 6437220 [TBL] [Abstract][Full Text] [Related]
29. Annual Albany College of Pharmacy prescription survey. DeNuzzo RV Med Mark Media; 1979 Apr; 14(4):15-6, 18-20, 22-5 passim. PubMed ID: 10241448 [No Abstract] [Full Text] [Related]
30. Biotech drugs: high costs becoming hard to swallow. Wagner M Mod Healthc; 1992 Jan; 22(2):24-5, 28-9. PubMed ID: 10115803 [TBL] [Abstract][Full Text] [Related]
31. Drug cost review--1987. Mehl B Hosp Pharm; 1988 Mar; 23(3):282-3. PubMed ID: 10318046 [No Abstract] [Full Text] [Related]
32. Use of 'treatment equivalents' supplements generics in controlling pharmacy costs. Cost Containment; 1980 Feb; 2(3):1. PubMed ID: 10309092 [No Abstract] [Full Text] [Related]
33. The use of pharmacy personnel to positively impact hospital finances. Hutchinson RA; Hatoum HT; Kolinski R; Riley DW Hosp Formul; 1989 Aug; 24(8):450, 453. PubMed ID: 10294357 [TBL] [Abstract][Full Text] [Related]
34. Drugmaker boycott may be expanded. Wagner M Mod Healthc; 1991 Oct; 21(43):9. PubMed ID: 10114646 [No Abstract] [Full Text] [Related]
35. How to crack the $2 billion hospital market for pharmaceuticals. Zellmer WA Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527 [No Abstract] [Full Text] [Related]
36. Investigational drug protocols--hidden costs. Mehl B Hosp Pharm; 1991 May; 26(5):459-61. PubMed ID: 10110663 [No Abstract] [Full Text] [Related]
37. DRG management. Many factors affect drug treatment costs. Mendenhall S Mod Healthc; 1985 Feb; 15(4):98-100. PubMed ID: 10273620 [No Abstract] [Full Text] [Related]
38. Cost analysis of substituting labetalol for nitroprusside. Mann HJ; Klecker RJ Am J Hosp Pharm; 1986 Jun; 43(6):1501-2. PubMed ID: 3728488 [No Abstract] [Full Text] [Related]
39. Drug wholesalers can help you cut inventory costs, speed turnover, and obtain planning assistance. Bowles GC Mod Hosp; 1973 May; 120(5):124. PubMed ID: 4786763 [No Abstract] [Full Text] [Related]
40. Pharmacy group buying could end discounts for not-for-profits, HMOs. Barkholz D Mod Healthc; 1985 Apr; 15(9):92. PubMed ID: 10271635 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]